Oxford Science Enterprises plc 4
4 · PepGen Inc. · Filed May 10, 2022
Insider Transaction Report
Form 4
PepGen Inc.PEPG
Transactions
- Conversion
Common Stock
[F1]2022-05-10+1,262,986→ 1,381,846 total - Conversion
Common Stock
[F1]2022-05-10+945,859→ 2,327,705 total - Conversion
Common Stock
[F1]2022-05-10+1,547,713→ 3,875,418 total - Conversion
Series A-1 Preferred stock
[F1]2022-05-10−1,285,720→ 0 total→ Common Stock (1,262,986 underlying) - Conversion
Series A-2 Preferred stock
[F1]2022-05-10−962,884→ 0 total→ Common Stock (945,859 underlying) - Conversion
Series B Preferred stock
[F1]2022-05-10−1,575,572→ 0 total→ Common Stock (1,547,713 underlying)
Footnotes (1)
- [F1]On May 10, 2022, each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 1.018-for-1 basis without payment of further consideration upon closing of the initial public offering of the Issuer's Common Stock. The shares of Preferred Stock had no expiration date.
Signature
Oxford Science Enterprises plc, Name: James Wilkinson, Title: Director|2022-05-10